Enfusion, Inc. Quarterly Operating Income (Loss) in USD from Q1 2021 to Q3 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Enfusion, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2021 to Q3 2024.
- Enfusion, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was $2.98M, a 10.9% increase year-over-year.
- Enfusion, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was $6.71M, a 40.1% decline year-over-year.
- Enfusion, Inc. annual Operating Income (Loss) for 2023 was $11.9M.
- Enfusion, Inc. annual Operating Income (Loss) for 2022 was -$12M, a 95.7% increase from 2021.
- Enfusion, Inc. annual Operating Income (Loss) for 2021 was -$276M, a 4642% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)